In Brief This Week: Source BioScience, Illumina; Verinata Health; PerkinElmer; Altona Diagnostics | GenomeWeb

NEW YORK (GenomeWeb News) – Source BioScience said this week that it has extended its next-generation sequencing services to include the Illumina MiSeq platform. The UK-based genomics services and molecular diagnostics firm said that it is the only commercial provider of the platform in the UK and added that the MiSeq will enable it to apply next-generation sequencing to molecular diagnostics.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.